161 related articles for article (PubMed ID: 21788040)
21. A second-look TUR in T1 transitional cell carcinoma: why?
Jakse G; Algaba F; Malmström PU; Oosterlinck W
Eur Urol; 2004 May; 45(5):539-46; discussion 546. PubMed ID: 15082193
[TBL] [Abstract][Full Text] [Related]
22. [Self-catheterizable urinary re-diversion using the appendix for urethral recurrence after ileal neobladder].
Ushida H; Masuda Y; Yoshida T; Okada Y
Hinyokika Kiyo; 2008 Nov; 54(11):749-52. PubMed ID: 19068732
[TBL] [Abstract][Full Text] [Related]
23. Surgical management of bladder urothelial carcinoma with squamous differentiation.
Raman JD; Jafri SM
Urol Oncol; 2015 Oct; 33(10):429-33. PubMed ID: 26206104
[TBL] [Abstract][Full Text] [Related]
24. Bladder cancer--resection/ablation.
Corica FA; Keane TE
Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
[No Abstract] [Full Text] [Related]
25. A randomized controlled trial of short-term versus long-term prophylactic intravesical instillation chemotherapy for recurrence after transurethral resection of Ta/T1 transitional cell carcinoma of the bladder.
Koga H; Kuroiwa K; Yamaguchi A; Osada Y; Tsuneyoshi M; Naito S
J Urol; 2004 Jan; 171(1):153-7. PubMed ID: 14665865
[TBL] [Abstract][Full Text] [Related]
26. [A second transurethral resection could be not necessary in all high grade non-muscle-invasive bladder tumors].
Gaya JM; Palou J; Cosentino M; Patiño D; Rodríguez-Faba O; Villavicencio H
Actas Urol Esp; 2012 Oct; 36(9):539-44. PubMed ID: 22710093
[TBL] [Abstract][Full Text] [Related]
27. Clinical utility of fluorescence in situ hybridization for prediction of residual tumor after transurethral resection of bladder urothelial carcinoma.
Ding T; Wang YK; Cao YH; Yang LY
Urology; 2011 Apr; 77(4):855-9. PubMed ID: 21296388
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with clinical T1 grade 3 urothelial cell bladder carcinoma treated with radical cystectomy.
Masood S; Mufti GR
Urology; 2008 Oct; 72(4):952; author reply 952. PubMed ID: 18926256
[No Abstract] [Full Text] [Related]
29. [Repeat transurethral resection for non-muscle invasive bladder cancer].
Shen YJ; Ye DW; Yao XD; Zhang SL; Dai B; Zhu YP; Zhang HL; Zhu Y; Shi GH; Ma CG
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):725-7. PubMed ID: 19615201
[TBL] [Abstract][Full Text] [Related]
30. Repeat transurethral resection lowers recurrence rates in T1 bladder tumors, even after intravesical mitomycin C.
Oosterlinck W
Nat Clin Pract Urol; 2006 Nov; 3(11):582-3. PubMed ID: 17088923
[No Abstract] [Full Text] [Related]
31. [Combination of endoscopic resection and external radiotherapy in carcinoma of the bladder].
Kahlain A; Bouras N; Sahraoui S; Acharki A; Benider A; Samlali R
Cancer Radiother; 1998 Apr; 2 Suppl 1():31s-33s. PubMed ID: 9749075
[TBL] [Abstract][Full Text] [Related]
32. [Prostatic urothelial location of a tumor of the bladder].
Coulange C; Lechevallier E; de Fromont M
Prog Urol; 1997 Feb; 7(1):128-31. PubMed ID: 9116731
[TBL] [Abstract][Full Text] [Related]
33. Transurethral en bloc resection with bipolar button electrode for non-muscle invasive bladder cancer.
Zhang J; Wang L; Mao S; Liu M; Zhang W; Zhang Z; Guo Y; Huang B; Yan Y; Huang Y; Yao X
Int Urol Nephrol; 2018 Apr; 50(4):619-623. PubMed ID: 29478198
[TBL] [Abstract][Full Text] [Related]
34. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
Al-Ali MA; Kashmoula DM; Haddad LF
Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
[TBL] [Abstract][Full Text] [Related]
35. Editorial comment on: Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.
Lotan Y
Eur Urol; 2008 Mar; 53(3):579-80. PubMed ID: 17804152
[No Abstract] [Full Text] [Related]
36. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
37. Carcinoma in a bladder diverticulum: presentation and treatment outcome.
Golijanin D; Yossepowitch O; Beck SD; Sogani P; Dalbagni G
J Urol; 2003 Nov; 170(5):1761-4. PubMed ID: 14532771
[TBL] [Abstract][Full Text] [Related]
38. Reply from authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: current role and future perspectives. Eur Urol 2010;58:191-2 and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with T1 bladder cancer? Why a flawed randomized controlled trial cannot address the issue. Eur Urol 2010;58:193-4.
Divrik RT; Sahin AF; Ergör G
Eur Urol; 2010 Aug; 58(2):195-6. PubMed ID: 20471156
[No Abstract] [Full Text] [Related]
39. Residual tumor discovered in routine second transurethral resection in patients with stage T1 transitional cell carcinoma of the bladder.
Klän R; Loy V; Huland H
J Urol; 1991 Aug; 146(2):316-8. PubMed ID: 1856924
[TBL] [Abstract][Full Text] [Related]
40. [Dysplastic urothelial changes in patients with bladder cancer].
Csapó Z; Kolozsy Z; Dauda G; Mohácsi L
Urologe A; 1984 Sep; 23(5):281-4. PubMed ID: 6542270
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
